工业工程2017，Vol.20Issue(5)：38-44,7.DOI:10.3969/j.issn.1007-7375.e16-1276
中国医药制造业技术创新系统协同演化分析
An Analysis on the Synergetic Evolution of Chinese Pharmaceutical Industry Technology Innovation System
摘要
Abstract
Based on the perspectives of technology innovation value chain and complex systems theory, the Chinese pharmaceutical industry technology innovation system can be deconstructed into four subsystems of internal technology R&D, external technology acquisition, commercialization and innovation supporting environment, to understand the evolution state and rule of this system. Using the data of statistical yearbook from 2007-2015 and the synergy degree model of composite system, this system's synergy degree and its subsystems' ordering degree in the evolution process are measured and analyzed. The results show that this system's overall synergy degree and its subsystems' ordering degree show a dynamically rising trend as time goes on but their average values are low; technology external acquisition subsystem is the restriction factor for the synergy development of the whole system to the high level; the influencing weights of different order parameters on their respective subsystems' ordering degree are different; the significant polices for China's pharmaceutical industry may produce a clear short-term effect on the system's synergy development. Finally, some policy recommendations are made based on the above conclusions.关键词
医药制造业/技术创新系统/协同度Key words
pharmaceutical industry/technology innovation system/synergy degree分类
管理科学引用本文复制引用
徐梦丹,朱桂龙,马文聪..中国医药制造业技术创新系统协同演化分析[J].工业工程,2017,20(5):38-44,7.基金项目
国家自然科学基金项目(71233003,71403060) （71233003,71403060）
教育部哲学社会科学研究重大课题攻关项目(12JZD042) （12JZD042）
广东省软科学研究计划项目(2014A070703058,2013B070207008) （2014A070703058,2013B070207008）
广东省哲学社会科学"十二五"规划项目(GD14XGL42,GD13YGL04) （GD14XGL42,GD13YGL04）
广东省高等教育"创新强校工程"特色创新项目(2015GXJK060) （2015GXJK060）
